CA2334652A1 - Inhibiteurs de proteases - Google Patents
Inhibiteurs de proteases Download PDFInfo
- Publication number
- CA2334652A1 CA2334652A1 CA002334652A CA2334652A CA2334652A1 CA 2334652 A1 CA2334652 A1 CA 2334652A1 CA 002334652 A CA002334652 A CA 002334652A CA 2334652 A CA2334652 A CA 2334652A CA 2334652 A1 CA2334652 A1 CA 2334652A1
- Authority
- CA
- Canada
- Prior art keywords
- leucyl
- alkyl
- pyrrolidin
- group
- pyrrolidine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Cette invention concerne des composés de formule (I) ou un sel pharmaceutiquement acceptable de ces derniers qui sont des inhibiteurs de cystéine protéases, particulièrement de la cathepsine K, et qui sont utilisés dans le traitement des maladies dans lesquelles la déperdition osseuse est un facteur.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8905698P | 1998-06-12 | 1998-06-12 | |
US60/089,056 | 1998-06-12 | ||
PCT/US1999/013334 WO1999064399A1 (fr) | 1998-06-12 | 1999-06-11 | Inhibiteurs de proteases |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2334652A1 true CA2334652A1 (fr) | 1999-12-16 |
Family
ID=22215426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002334652A Abandoned CA2334652A1 (fr) | 1998-06-12 | 1999-06-11 | Inhibiteurs de proteases |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP1086083A4 (fr) |
JP (1) | JP2002517485A (fr) |
AR (1) | AR018652A1 (fr) |
AU (1) | AU4564499A (fr) |
CA (1) | CA2334652A1 (fr) |
CO (1) | CO5040090A1 (fr) |
DZ (1) | DZ2815A1 (fr) |
MA (1) | MA24877A1 (fr) |
PE (1) | PE20000725A1 (fr) |
WO (1) | WO1999064399A1 (fr) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030144175A1 (en) | 1998-12-23 | 2003-07-31 | Smithkline Beecham Corporation | Protease inhibitors |
EP1232155A4 (fr) | 1999-11-10 | 2002-11-20 | Smithkline Beecham Corp | Inhibiteurs de protease |
WO2001034600A1 (fr) | 1999-11-10 | 2001-05-17 | Smithkline Beecham Corporation | Inhibiteurs de protease |
JP2003513924A (ja) | 1999-11-10 | 2003-04-15 | スミスクライン・ビーチャム・コーポレイション | プロテア−ゼ阻害剤 |
SK13632002A3 (sk) | 2000-03-21 | 2003-02-04 | Smithkline Beecham Corporation | C1-6-alkyl-4-amino-azepán-3-ónové zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom, ich použitie a medziprodukty |
US20020156063A1 (en) * | 2001-04-06 | 2002-10-24 | Setti Eduardo L. | Arylacetamido-ketobenzoxazole as cysteine protease inhibitors |
US7282512B2 (en) | 2002-01-17 | 2007-10-16 | Smithkline Beecham Corporation | Cycloalkyl ketoamides derivatives useful as cathepsin K inhibitors |
WO2009087379A2 (fr) | 2008-01-09 | 2009-07-16 | Amura Therapeutics Limited | Composés |
WO2023041432A1 (fr) | 2021-09-14 | 2023-03-23 | Boehringer Ingelheim International Gmbh | Dérivés de 3-phénoxyazétidin-1-yl-hétéroaryl-pyrrolidine et leur utilisation en tant que médicament |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ134296A3 (en) * | 1993-11-09 | 1996-12-11 | Merck & Co Inc | Piperidine, pyrrolidine and hexahydro-1h-azepine derivatives, process of their preparation and pharmaceutical compositions containing thereof |
US5770573A (en) * | 1993-12-06 | 1998-06-23 | Cytel Corporation | CS-1 peptidomimetics, compositions and methods of using the same |
US5618792A (en) * | 1994-11-21 | 1997-04-08 | Cortech, Inc. | Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase |
-
1999
- 1999-06-09 DZ DZ990115A patent/DZ2815A1/fr active
- 1999-06-10 CO CO99036559A patent/CO5040090A1/es unknown
- 1999-06-10 AR ARP990102767A patent/AR018652A1/es unknown
- 1999-06-10 MA MA25619A patent/MA24877A1/fr unknown
- 1999-06-11 PE PE1999000518A patent/PE20000725A1/es not_active Application Discontinuation
- 1999-06-11 WO PCT/US1999/013334 patent/WO1999064399A1/fr not_active Application Discontinuation
- 1999-06-11 CA CA002334652A patent/CA2334652A1/fr not_active Abandoned
- 1999-06-11 JP JP2000553408A patent/JP2002517485A/ja not_active Withdrawn
- 1999-06-11 EP EP99928614A patent/EP1086083A4/fr not_active Withdrawn
- 1999-06-11 AU AU45644/99A patent/AU4564499A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DZ2815A1 (fr) | 2003-12-01 |
CO5040090A1 (es) | 2001-05-29 |
WO1999064399A1 (fr) | 1999-12-16 |
AR018652A1 (es) | 2001-11-28 |
MA24877A1 (fr) | 1999-12-31 |
EP1086083A1 (fr) | 2001-03-28 |
PE20000725A1 (es) | 2000-09-28 |
JP2002517485A (ja) | 2002-06-18 |
EP1086083A4 (fr) | 2001-09-26 |
AU4564499A (en) | 1999-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2262668C (fr) | Inhibiteurs de la cathepsine k | |
US6369077B1 (en) | Protease inhibitors | |
WO1998008802A1 (fr) | Inhibiteurs de cysteine protease | |
NZ337889A (en) | Cysteine Protease inhibitors of the Papain superfamily comprising cathepsin K protease inhibitors | |
CA2334652A1 (fr) | Inhibiteurs de proteases | |
US20020128476A1 (en) | Inhibitors of cysteine protease | |
EP1235577A2 (fr) | Inhibiteurs de protease | |
US6596715B1 (en) | Protease inhibitors | |
WO2000029408A1 (fr) | Inhibiteurs de morpholino-ethoxybenzofuran protease | |
US6534498B1 (en) | Protease inhibitors | |
EP1231921A1 (fr) | Inhibiteurs de proteases | |
WO2001034160A1 (fr) | Inhibiteurs de protease | |
WO2000058296A1 (fr) | Inhibiteurs de protease | |
WO2001034155A1 (fr) | Inhibiteurs de protease | |
US20020082426A1 (en) | Protease inhibitors | |
US6583137B1 (en) | Protease inhibitors | |
EP1231923A1 (fr) | Inhibiteurs de protease | |
CA2285601A1 (fr) | Inhibiteurs de proteases | |
EP1384713B1 (fr) | Derives de 4-amino-azepan-3-one comme inhibiteurs de protease | |
US20020165222A1 (en) | Protease inhibitors | |
MXPA99010254A (en) | Protease inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |